Companies › CRVO
CERVOMED INC (CRVO)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001053691 · EDGAR filings · Updated 2026-07-14
CERVOMED INC (CRVO) has reported institutional ownership of 19.1%, with 36 institutional managers holding positions valued at $6.97M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.
Latest updates
- 2026-07-14 — Current report (8-K) filed
- 2026-07-10 — EFFECT filed
- 2026-07-10 — Prospectus supplement (424B3) filed
- 2026-07-09 — Current report (8-K) filed
- 2026-07-08 — SCHEDULE 13G/A filed
- 2026-07-06 — Shelf registration (S-3) filed
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, CERVOMED INC has 36 institutional holders and institutional ownership of 19.1%.
Insider activity
Insiders reported 19 transactions (19 buys, 0 sells) across 4 reporting insiders, with a net reported value of $773.5K.
Data flags from SEC filings
Related companies
Koninklijke Philips NV (PHG) · NEUPHORIA THERAPEUTICS IN (NEUP) · Kyntra Bio Inc (KYNB) · TEVOGEN BIO HOLDINGS INC (TVGN) · Lite Strategy Inc (LITS) · DarioHealth Corp (DRIO)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-14.